Changes in medication availability can be concerning for patients and caregivers.
If your current urea cycle disorder (UCD) treatment is no longer available or may soon become unavailable, it may be time to discuss alternative treatment options with your UCD specialist.

Branded RAVICTI® (glycerol phenylbutyrate) oral liquid is expected to be retired in the U.S. on December 31, 2026 and in Canada in 2027.
FDA approved generic glycerol phenylbutyrate products may be available in the United States.
Patients currently taking Ravicti® should speak to their healthcare provider about the availability of their medication and discuss appropriate treatment options and potential changes to their treatment. Patients should not discontinue or change their medications without first consulting their healthcare provider.
Every patient with a UCD has unique treatment needs. Do not stop, start, or change your medication without first speaking with your UCD specialist or healthcare provider. Your healthcare team can help determine whether a different treatment option is appropriate for you and guide you through any transition.
When treatment changes unexpectedly, confidence matters. Pheburane® is a proven UCD treatment that provides patients with a palatable, taste-masked formulation and the reassurance of receiving the same trusted medication with every refill.
A treatment change can feel overwhelming, but you don't have to navigate it alone. Combined with comprehensive patient support and broad insurance coverage, Pheburane® can help make the transition to a new treatment as smooth as possible.
Talk with your UCD specialist to see if Pheburane® may be right for you.
Pheburane® is a prescription medicine, used along with a specific diet, for the long-term management of adults and children with certain urea cycle disorders (UCDs). Episodes of sudden, rapid increase of ammonia in the blood (acute hyperammonemia) may happen in people during treatment with Pheburane®. Pheburane® is not used for the treatment of acute hyperammonemia, which can be life-threatening and requires emergency medical treatment.
The most common side effects include absent or irregular menstrual periods, decreased appetite, body odor, and bad taste or avoiding foods that you ate prior to getting sick (taste aversion).
Used in Europe since 2013 and Canada since 2015
Pheburane® offers a comprehensive patient support program – the UNIK Support program – designed to help you navigate treatment and access resources throughout your treatment journey.

*See terms and conditions here
Do not stop, start, or change your medication without first speaking with your UCD specialist or healthcare provider. Your healthcare team can help determine whether a different treatment option is appropriate for you and guide you through any transition.
Pheburane® is an available treatment option for certain UCDs with broad commercial and Medicaid insurance coverage and offers copay/financial assistance through its UNIK Support Program.
Pheburane® is a proven UCD treatment that provides patients with a palatable, taste-masked formulation of sodium phenylbutyrate consisting of very small coated oral pellets (about the size of sugar crystals).
Pheburane® is a prescription medicine, used along with a specific diet, for the long-term management of adults and children with certain urea cycle disorders (UCDs). Episodes of sudden, rapid increase of ammonia in the blood (acute hyperammonemia) may happen in people during treatment with Pheburane®. Pheburane® is not used for the treatment of acute hyperammonemia, which can be life-threatening and requires emergency medical treatment.
The most common side effects include absent or irregular menstrual periods, decreased appetite, body odor, and bad taste or avoiding foods that you ate prior to getting sick (taste aversion).
Learn moreNo. Pheburane® contains sodium phenylbutyrate, which is a different active ingredient from glycerol phenylbutyrate. Both forms remove the same amount of excess ammonia in the blood. The two medicines have different dosage forms, dosing and approved uses, and Pheburane® is not a generic version of any other medicine. Only your healthcare provider can decide which treatment is right for you.
There are 2 ways you can take Pheburane®. Plan to take your Pheburane® dose at the same time as food consumption (meal or snack):
It is important to swallow right away (within 10 seconds) to prevent the coating from starting to dissolve.
*Taking Pheburane® with other foods has not been studied and is not recommended. Pheburane® should only be taken with soft foods if the child is old enough to eat soft foods.
Learn moreNot necessarily. Your healthcare provider will prescribe Pheburane® based on your or your child's weight and may change your dose if needed. Take Pheburane® exactly as prescribed and do not change your dose unless your healthcare provider tells you to.
Tell your healthcare provider about all your medical conditions, including if you:
Pheburane® can cause serious side effects, including:
Nervous system problems (neurotoxicity). Call your healthcare provider right away if you get any of the following symptoms during treatment with Pheburane®:
Low potassium levels in your blood (hypokalemia). Your healthcare provider will monitor your blood potassium levels during treatment with Pheburane® and treat if needed.
Conditions related to swelling (edema). Pheburane® contains salt (sodium), which can cause swelling from salt and water retention. Your healthcare provider will decide if Pheburane® is right for you if you have certain medical conditions that can cause swelling, such as heart failure, liver problems or kidney problems.
The most common side effects of Pheburane® include:
No. Do not give or take Pheburane® through a gastrostomy or nasogastric tube.
Medunik USA offers the UNIK Support Program, which includes personalized, one-on-one educational support, copay/financial assistance, and mail-order pharmacy services.
Learn moreWhat is Pheburane®?
Beforetaking Pheburane®, tell your healthcare provider about all of your medical conditions, including if you:
Tell your healthcare provider about all the medicines you or your child take, including prescription and over-the-counter medicines, vitamins, and herbal supplements.
Certain medicines may increase the level of ammonia in your blood or cause serious side effects when taken during treatment with Pheburane®. Especially tell your healthcare provider if you or your child take:
Know the medicines you take. Keep a list of them to show your or your child’s healthcare provider and pharmacist when you get a new medicine.
What are the possible side effects of Pheburane®?
Pheburane® can cause serious side effects, including: Nervous system problems (neurotoxicity).
Call your healthcare provider right away if you get any of the following symptoms during treatment with Pheburane®:
Low potassium levels in your blood (hypokalemia). Your healthcare provider will monitor your blood potassium levels during treatment with PHEBURANE and treat if needed.
Conditions related to swelling (edema).Pheburane® contains salt (sodium), which can cause swelling from salt and water retention. Your healthcare provider will decide if PHEBURANE is right for you if you have certain medical conditions that can cause swelling, such as heart failure, liver problems or kidney problems.
The most common side effects of Pheburane® include:
Your healthcare provider may do certain blood tests to check you or your child for side effects during treatment with Pheburane®.
These are not all the possible side effects of Pheburane®.
Call your doctor for medical advice about side effects.
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch. or call 1-800-FDA-1088.
Please read the Full Prescribing Information, the Patient Information. and the Instruction for Use. before taking Pheburane® oral pellets and each time you get a refill.